SKSu-Yeong Kim

Su-Yeong Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Su-Yeong Kim has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Genotoxicity of Gagam-Jokyung-tang

    by Seong Min Hwang, Sung Young Cho, Su Yeong Kim, Jong Hyun Nho

    Objectives: This study was conducted to evaluate the genotoxic potential of Gagam-jokyung-tang.Methods: Genotoxicity was assessed using a bacterial reverse mutation test (Ames test), an in vitro mammalian chromosomal aberration test, and an in vivo micronucleus test. The bacterial reverse mutation test was performed using Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537 and Escherichia coli WP2uvrA in the presence and absence of metabolic activation. The chromosomal aberration test was conducted in cultured mammalian cells under both metabolic activation and non-activation conditions. The micronucleus test was performed in ICR mice, and the frequency of micronucleated polychromatic erythrocytes in bone marrow cells was evaluated following oral administration of the test substance.Results: The test substance did not induce an increase in revertant colonies in any of the bacterial strains tested. In the chromosomal aberration test, no significant increase in structural chromosomal aberrations was observed compared with the negative control. In the micronucleus test, the frequency of micronucleated polychromatic erythrocytes was not increased in the treated groups, and no changes in the PCE/(PCE+NCE) ratio were observed.Conclusions: These results indicate that Gagam-jokyung-tang freeze-dried extract did not exhibit genotoxic potential under the conditions of the present study and may provide basic safety data for the development and safety evaluation of Gagam-jokyung-tang preparations.

  • Open Access

    Safety Evaluation of the Liriope platyphylla Water Extract by Bacterial Reverse Mutation Test and Acute Oral Toxicity Study

    by Seong Min Hwang, Sung Young Cho, Su Yeong Kim, Jong Hyun Nho

    Objectives: Liriope platyphylla has been traditionally used in Korean medicine for relieving cough, reducing lung heat, and nourishing the yin. However, scientific data regarding the safety of its water extract reamins insufficient. This study was conducted to evaluate the genotoxicity and acute oral toxicity of the Liriope platyphylla water extract through a bacterial reverse mutation test and a single-dose oral toxicity study in rats.Methods: This study evaluated the genotoxic and acute oral toxicity of the Liriope platyphylla water extract. A bacterial reverse mutation assay (Ames test) was conducted using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, as well as Escherichia coli WP2 uvrA, both with and without metabolic activation (S9 mix). Additionally, a single-dose oral toxicity study was performed in Sprague-Dawley rats according to OECD Test Guideline 423.Results: No increase in revertant colonies or dose-dependent mutagenicity was observed in any strain, regardless of the presence of S9 mix. In the acute oral toxicity test, no mortality, clinical signs, or pathological changes were found at doses up to 2,000 mg/kg.Conclusions: These results suggest that the Liriope platyphylla water extract is non-mutagenic and does not exhibit acute oral toxicity after single-dose administration, supporting its potential safety as a herbal resource for further development


  • Open Access

    Non-clinical safety evaluation of Mangeum-tang

    by Sung-Min Hwang, Sung-Young Jo, Su-Yeong Kim, Jun-Sub Kim, Hyun-Woo Cho, Jong-Hyun Nho

    In South Korea, the traditional use of Korean medicine is recognized by the government, with efforts being made to expand its inclusion in health insurance. However, unlike pharmaceutical drugs, traditional medicines are used in clinical practice without proper non-clinical and clinical trial validation, raising criticism and concerns. Mangeum-tang is commonly used for treating sequelae from stroke and neuralgia. The rhizome of Cnidium officinale MAKINO, included in Mangeum-tang, is known to reduce embryonic growth and development in rats and induce mild limb malformations, raising safety concerns. The causes of malformations are diverse, often linked to genotoxicity, prompting toxicity investigations. In vitro, Mangeum-tang did not induce genetic mutations or chromosomal aberration, and in vivo, it did not cause micronucleus formation or acute toxicity in hematopoietic cells. Therefore, Mangeum-tang does not appear to induce acute toxicity or genotoxicity. However, the studies conducted were short-term, and toxicity from repeated administration has not been confirmed. To ensure the safety of Mangeum-tang, further studies, including repeated-dose toxicity tests, carcinogenicity tests, reproductive toxicity tests, and additional research on the genotoxicity of Cnidium officinale MAKINO, are necessary.


  • Open Access

    Safety assessment of Gami-daebo-tang gagambang used for treating stroke sequelae

    by Sung-Min Hwang, Sung-Young Jo, Su-Yeong Kim, Jong-Hyun Nho

    Objectives: This study aimed to investigate wheter Gami-daebo-tang gagambang, commonly used for treating stroke sequelae, induces acute toxicity or genetoxicity.Methods: Gami-daebo-tang gagambang contains that the root of Angelica gigas Nakai inducing acute headache and weakness, and the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Gami-daebo-tang gagambang induces acute toxicity and genotoxicity in accordance with Korean non-clinical test standards and OECD test guidelines TG471, TG473, TG474.Results: When male and female rats were given a single dose of Gami-daebo-tang gagambang, no toxic effects or organ damage were observed at dosages reaching 2,500 mg/kg. The bacterial reverse mutation assay showed no evidence of DNA mutations at concentrations up to 5,000 μg/plate. In vitro studies indicated that Gami-daebo-tang gagambang did not cause structural or numerical chromosomal aberrations at concentrations as high as 2,000 μg/mL. Moreover, animal studies demonstrated that the substance did not induce bone marrow toxicity or the formation of micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions: The studies conducted with different models showed that Gami-daebo-tang gagambang did not cause acute toxicity or genotoxicity. This study provides evidence for the safety of Gami-daebo-tang gagambang in terms of acute toxicity and genotoxicity, supporting its potential safe application in treating stroke sequelae.


  • Open Access

    Acute toxicity and genotoxicity assessment of Ligigeopoong-san

    by Sung-Young Jo, Sung-Min Hwang, Su-Yeong Kim, Jun-Sub Kim, Kyeong-Wan Woo, Hyun-Woo Cho, Jong-Hyun Nho

    Objectives: This study aimed to investigate whether Ligigeopoong-san induces acute toxicity and genotoxicityMethods: Ligigeopoong-san contains the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Ligigeopoong-san induces acute toxicity and genotoxicity using various experimental models in accordance with Korean non-clinical test standards for pharmaceuticals and OECD test guidelines.Results : When Ligigeopoong-san was administered as a single dose to male and female rats, no toxic reactions, including organ damage, were observed at doses up to 2,500 mg/kg. In the bacterial reverse mutation test, no DNA mutations were detected at concentrations up to 5,000 μg/plate. In cell models, Ligigeopoong-san did not induce structural or numerical chromosomal aberrations at concentrations up to 2,000 μg/mL. Additionally, in animal studies, it did not cause bone marrow toxicity or form micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions : The experiments using various models demonstrated that Ligigeopoong-san did not induce acute toxicity or genotoxicity.